Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter M Irving

Showing results (1-10 of 194) with videos related to

Pageof 20
Sort By:
Digestive Diseases (Basel, Switzerland)|June 28, 2014
Are we using and monitoring thiopurines and biologics optimally?Peter M Irving
Best Practice & Research. Clinical Gastroenterology|June 11, 2014
Can we get more from our current treatments?Peter M Irving
The American Journal of Gastroenterology|January 13, 2006
Leukocytapheresis in ulcerative colitisPeter M Irving
Clinical Medicine (London, England)|January 26, 2010
Recent advances in the management of inflammatory bowel diseasePeter M Irving
Journal of Crohn'S & Colitis|May 4, 2023
Thiopurines for Ulcerative Colitis: Old Favourite or Old Hat?Peter M Irving
Expert Review of Gastroenterology & Hepatology|April 28, 2015
Toxicity and response to thiopurines in patients with inflammatory bowel diseaseRimma Goldberg, Peter M Irving
Expert Opinion on Biological Therapy|October 3, 2024
An evaluation of mirikizumab for the treatment of ulcerative colitisChristopher White, Peter M Irving
Journal of Gastroenterology and Hepatology|August 18, 2009
Biologics for inflammatory bowel diseases in the Asia-Pacific: can we afford to use them, can we afford not to?Richard B Gearry, Peter M Irving
Expert Review of Clinical Immunology|July 6, 2017
Optimising use of thiopurines in inflammatory bowel diseaseRobin J Dart, Peter M Irving
Journal of Crohn'S & Colitis|March 12, 2020
Authors' Reply to: Type C Mucosa in Pouch Surveillance: Make-do and Mend Rather Than Start From Scratch?Mark A Samaan, Peter M Irving
Pageof 20

Showing results (1-10 of 194) with videos related to

Sort By:
Pageof 20
Digestive Diseases (Basel, Switzerland)|June 28, 2014
Are we using and monitoring thiopurines and biologics optimally?Peter M Irving
Best Practice & Research. Clinical Gastroenterology|June 11, 2014
Can we get more from our current treatments?Peter M Irving
The American Journal of Gastroenterology|January 13, 2006
Leukocytapheresis in ulcerative colitisPeter M Irving
Clinical Medicine (London, England)|January 26, 2010
Recent advances in the management of inflammatory bowel diseasePeter M Irving
Journal of Crohn'S & Colitis|May 4, 2023
Thiopurines for Ulcerative Colitis: Old Favourite or Old Hat?Peter M Irving
Expert Review of Gastroenterology & Hepatology|April 28, 2015
Toxicity and response to thiopurines in patients with inflammatory bowel diseaseRimma Goldberg, Peter M Irving
Expert Opinion on Biological Therapy|October 3, 2024
An evaluation of mirikizumab for the treatment of ulcerative colitisChristopher White, Peter M Irving
Journal of Gastroenterology and Hepatology|August 18, 2009
Biologics for inflammatory bowel diseases in the Asia-Pacific: can we afford to use them, can we afford not to?Richard B Gearry, Peter M Irving
Expert Review of Clinical Immunology|July 6, 2017
Optimising use of thiopurines in inflammatory bowel diseaseRobin J Dart, Peter M Irving
Journal of Crohn'S & Colitis|March 12, 2020
Authors' Reply to: Type C Mucosa in Pouch Surveillance: Make-do and Mend Rather Than Start From Scratch?Mark A Samaan, Peter M Irving
Pageof 20